DKA guidance shared

A clinical guideline does not usually break out of the hospital intranet. This one did. A post circulating on social media pushed fresh attention onto the Joint British Diabetes Societies guidance for diabetic ketoacidosis, or DKA, the most dangerous acute emergency in insulin deficiency. The document itself is not brand new. The current adult JBDS guideline was revised in March 2023, with a one-page treatment pathway and nursing supplement released alongside it, and it still sits prominently on the JBDS and Diabetes UK guidance pages. (abcd.care) That matters because DKA is both familiar and unforgiving. It happens when too little effective insulin lets the body switch hard into ketone production, driving metabolic acidosis along with dehydration and usually marked hyperglycemia. The 2024 international consensus report, which included JBDS authors, described DKA and hyperosmolar hyperglycemic state as the two most serious acute hyperglycemic emergencies in diabetes and noted that admissions have risen over the past decade. (diabetesjournals.org) The JBDS pathway is built around speed and standardization. It defines DKA in adults by the presence of all three findings together: blood glucose above 11 mmol/L, blood ketones above 3 mmol/L or urine ketones at least ++, and venous pH below 7.3 or bicarbonate below 15 mmol/L. Once that picture is confirmed, the pathway moves immediately to intravenous 0.9% sodium chloride, a fixed-rate intravenous insulin infusion at 0.1 units per kilogram per hour, and close monitoring of glucose, ketones, bicarbonate, potassium, observations, and fluid balance. (abcd.care) The practical details are the point. If systolic blood pressure is under 90 mmHg, the pathway calls for a 500 mL bolus of 0.9% sodium chloride over 10 to 15 minutes while senior help is sought. If pressure is higher, it still starts with a liter of saline over the first hour. The document also tells teams not to stop a patient’s usual long-acting basal insulin if they already take it. That instruction looks small on the page, but it addresses a common failure mode in real admissions, where insulin gets interrupted and the metabolic crisis drags on. (abcd.care) The guideline is also trying to prevent treatment from creating a second emergency. It flags more cautious fluid replacement for young adults, older people, pregnancy, and heart or renal failure. It advises continuous reassessment if ketones and glucose are not falling as expected, including the very basic check that the insulin pump is actually working and connected and that the right residual volume is present. In other words, the pathway is written for the messy reality of acute care, not the tidy version. (abcd.care) That helps explain why a social-media share would travel beyond clinicians. DKA is a hospital problem that often begins at home. The early clues are not exotic: thirst, passing urine a lot, vomiting, abdominal pain, exhaustion, fast breathing, and progressive confusion. The JBDS materials are professional guidance, not patient education, but the public interest around them reflects something real. People using insulin, and the relatives who may be the first to notice that something is wrong, live in the gap between symptom recognition and emergency treatment. (bestpractice.bmj.com) The wider context is that DKA guidance is still moving. Diabetes UK’s JBDS page now highlights the July 2024 global consensus publication on hyperglycemic crises alongside the March 2023 UK DKA guideline. That newer consensus brought the British group into a broader international update after years without one. So the post that spread this week was not just recirculating a PDF. It was pulling attention back to a protocol that hospitals still use, in a field where the stakes are measured in hours, potassium levels, and whether someone remembered to keep the basal insulin going. (diabetes.org.uk)